Account Executive - MI Clarity - Philadelphia-New Jersey South
Caris Life Sciences
August 21, 2026
Remote friendly (New Jersey, United States)
United States
Sales
Position: Account Executive – MI Clarity
Responsibilities:
- Drive awareness, adoption, and utilization of MI Clarity (AI-powered prognostic assay for early and late distant recurrence risk in eligible HR+/HER2-, node-negative postmenopausal breast cancer patients).
- Educate oncologists, breast surgeons, pathologists, nurse navigators, and healthcare systems on clinical utility and evidence.
- Present clinical/validation data; explain differentiation vs traditional genomic/molecular assays.
- Lead in-person/virtual consultative discussions on risk stratification, treatment planning, extended endocrine therapy, and reducing overtreatment/undertreatment.
- Position MI Clarity as clinical decision support (performance, patient selection, workflow integration, turnaround time, interpretation).
- Develop territory/account plans; identify and engage KOLs/champions.
- Support workflow implementation and operational integration.
- Analyze account performance; develop targeted engagement strategies.
- Maintain CRM documentation, forecasting, and activity records.
- Ensure compliant, accurate promotional/clinical communications.
Required Qualifications:
- Bachelor’s degree (life sciences/healthcare preferred).
- 3+ years sales in Oncology/Diagnostics/Molecular Testing/Pathology/Medical Device/Pharma.
- Strong breast cancer/oncology knowledge; ability to interpret/communicate clinical data.
- Proven relationship-building with providers and health systems; consultative selling.
- Ability to travel within assigned territory.
Preferred Qualifications:
- Oncology diagnostics/precision medicine sales; existing oncology/breast center relationships.
- Experience launching new assays; pathology/digital pathology familiarity.
- Knowledge of prognostic/predictive breast cancer assays; provider engagement; workflow implementation; market penetration.
Annual Hiring Range: $125,000–$145,000 (actual may vary by location/experience).
Responsibilities:
- Drive awareness, adoption, and utilization of MI Clarity (AI-powered prognostic assay for early and late distant recurrence risk in eligible HR+/HER2-, node-negative postmenopausal breast cancer patients).
- Educate oncologists, breast surgeons, pathologists, nurse navigators, and healthcare systems on clinical utility and evidence.
- Present clinical/validation data; explain differentiation vs traditional genomic/molecular assays.
- Lead in-person/virtual consultative discussions on risk stratification, treatment planning, extended endocrine therapy, and reducing overtreatment/undertreatment.
- Position MI Clarity as clinical decision support (performance, patient selection, workflow integration, turnaround time, interpretation).
- Develop territory/account plans; identify and engage KOLs/champions.
- Support workflow implementation and operational integration.
- Analyze account performance; develop targeted engagement strategies.
- Maintain CRM documentation, forecasting, and activity records.
- Ensure compliant, accurate promotional/clinical communications.
Required Qualifications:
- Bachelor’s degree (life sciences/healthcare preferred).
- 3+ years sales in Oncology/Diagnostics/Molecular Testing/Pathology/Medical Device/Pharma.
- Strong breast cancer/oncology knowledge; ability to interpret/communicate clinical data.
- Proven relationship-building with providers and health systems; consultative selling.
- Ability to travel within assigned territory.
Preferred Qualifications:
- Oncology diagnostics/precision medicine sales; existing oncology/breast center relationships.
- Experience launching new assays; pathology/digital pathology familiarity.
- Knowledge of prognostic/predictive breast cancer assays; provider engagement; workflow implementation; market penetration.
Annual Hiring Range: $125,000–$145,000 (actual may vary by location/experience).